Literature DB >> 18365577

In-vivo evaluation of the BioPhysio valve prosthesis in the aortic position.

Mirko Doss1, Petar Risteski, Jeffrey P Wood, Gerhard Wimmer-Greinecker, Anton Moritz.   

Abstract

BACKGROUND AND AIM OF THE STUDY: The new BioPhysio aortic prosthesis is a pericardial valve with a flexible stent that can be implanted with a single suture line. The study aim was to evaluate the in-vivo implantation characteristics, preservation of dynamic motion of the aortic root, and hemodynamic performance of this bioprosthesis.
METHODS: The BioPhysio valve was implanted, in the aortic position, in 10 young adult male sheep. Transesophageal and intracardiac echocardiography were carried out postoperatively for hemodynamic evaluation. Cineangiography was performed both preoperatively and postoperatively to assess aortic root dynamics and to document the absence of aortic regurgitation. Cardiac output was monitored via a Swan-Ganz catheter, both preoperatively and postoperatively.
RESULTS: The BioPhysio valve was implanted with interrupted mattress sutures in seven cases, and with continuous sutures in three cases. At a mean cardiac output of 5.9 l/min, the mean transaortic pressure gradients were 5.93 and 3.6 mmHg for the 19- and 21-mm valves, respectively, and the mean effective orifice areas were 2.08 and 2.65 cm2. Mean dilation of the aortic root, measured as the maximum expansion of the radiopaque frame in systole, was 9.01%.
CONCLUSION: The unique flexible stent design of the new BioPhysio valve preserves the dynamic motion of the aortic root, by combining the hemodynamic benefits of stentless valves with the ease of implantation of stented bioprostheses.

Entities:  

Mesh:

Year:  2008        PMID: 18365577

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  1 in total

1.  Strategies to Improve Survival from Surgery for Heart Valve Implantation in Sheep.

Authors:  Annemijn Vis; Jan Cam Lammers; Roel de Vroege; Martijn Mj van Nieuwburg; Marlijn S Jansen; Joyce Mj Visser; Bart Meuris; Paul F Gründeman; Jolanda Kluin
Journal:  Comp Med       Date:  2021-06-03       Impact factor: 0.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.